These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10382877)

  • 21. Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction.
    Stass H; Kubitza D; Halabi A; Delesen H
    Br J Clin Pharmacol; 2002 Mar; 53(3):232-7. PubMed ID: 11874385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration.
    Stass H; Kubitza D; Schühly U
    Clin Pharmacokinet; 2001; 40 Suppl 1():1-9. PubMed ID: 11352436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis.
    Miyazaki E; Miyazaki M; Chen JM; Chaisson RE; Bishai WR
    Antimicrob Agents Chemother; 1999 Jan; 43(1):85-9. PubMed ID: 9869570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers.
    Stass H; Schühly U; Möller JG; Delesen H
    Clin Pharmacokinet; 2001; 40 Suppl 1():49-55. PubMed ID: 11352442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and tissue distribution of galantamine and galantamine-related radioactivity after single intravenous and oral administration in the rat.
    van Beijsterveldt L; Geerts R; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W
    Arzneimittelforschung; 2004; 54(2):85-94. PubMed ID: 15038457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of probenecid on the kinetics of a single oral 400mg dose of moxifloxacin in healthy male volunteers.
    Stass H; Sachse R
    Clin Pharmacokinet; 2001; 40 Suppl 1():71-6. PubMed ID: 11352445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative assessment of ocular tissue distribution of drug-related radioactivity after chronic oral administration of 14C-levofloxacin and 14C-chloroquine in pigmented rats.
    Tanaka M; Takashina H; Tsutsumi S
    J Pharm Pharmacol; 2004 Aug; 56(8):977-83. PubMed ID: 15285841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens.
    Goudah A
    Br Poult Sci; 2009 Mar; 50(2):251-8. PubMed ID: 19373726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics, tissue distribution, and excretion of sitafloxacin, a new fluoroquinolone antibiotic, in rats, dogs, and monkeys.
    Tachibana M; Tanaka M; Mitsugi K; Jin Y; Takaichi M; Okazaki O
    Arzneimittelforschung; 2004; 54(12):898-905. PubMed ID: 15646375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.
    Simon N; Sampol E; Albanese J; Martin C; Arvis P; Urien S; Lacarelle B; Bruguerolle B
    Clin Pharmacol Ther; 2003 Oct; 74(4):353-63. PubMed ID: 14534522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
    Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics of nitrendipine. II. Distribution to and elimination from organs and tissues of rats and dogs after single or repeated administration of [14C]nitrendipine.
    Krause HP; Ahr HJ; Siefert HM; Steinke W; Suwelack D
    Arzneimittelforschung; 1988 Nov; 38(11):1599-604. PubMed ID: 3214443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of iron supplements on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in humans.
    Stass H; Kubitza D
    Clin Pharmacokinet; 2001; 40 Suppl 1():57-62. PubMed ID: 11352443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration.
    Goudah A; Hasabelnaby S
    Res Vet Sci; 2010 Jun; 88(3):507-11. PubMed ID: 20004428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients.
    Lindstrom R; Lane S; Cottingham A; Smith S; Sall K; Silverstein S; Shettle L; Walters T; Faulkner R; Cockrum P; Teuscher N
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):591-5. PubMed ID: 20925517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in vitro and in vivo activity of the C-8 methoxy quinolone moxifloxacin and the C-8 chlorine quinolone BAY y 3118.
    Dalhoff A
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S16-22. PubMed ID: 11249824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
    Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
    Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus.
    Gehanno P; Darantière S; Dubreuil C; Chobaut JC; Bobin S; Pages JC; Renou G; Bobin F; Arvis P; Stass H
    J Antimicrob Chemother; 2002 May; 49(5):821-6. PubMed ID: 12003977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.